Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Why Traders Are Buzzing about These Stocks: Yahoo, Alibaba, and More

Alibaba Not Interested In Buying Paramount

Although Alibaba founder Jack Ma recently met with Shari Redstone, the daughter of the controlling shareholder of Viacom, Inc. (NASDAQ:VIAB), Sumner Redstone, it seems that Alibaba Group Holding Ltd (NYSE:BABA) isn’t interested in purchasing the company’s Paramount Pictures unit. According to The Street, the e-commerce giant is more interested in licensing deals instead. Alibaba has been a serial acquirer since its IPO and certainly has the resources to pull the deal off if it wanted to. At the end of March, 67 elite funds tracked by us owned shares of Alibaba Group Holding Ltd (NYSE:BABA).

Technical Selling Detected at Valeant 

Valeant Pharmaceuticals Intl Inc (NYSE:VRX) has declined by 4% today amid broader market weakness. The company’s stock has been in a sharp downtrend due to concerns that its considerable debt load and inability to raise prices as before could hurt the company’s earnings results. Valeant is also in the news today after announcing the launch of a new PreserVision AREDS 2 Formula + Multivitamin. The new version is made by Valeant’s Bausch + Lomb division, which some traders regard as the company’s crown jewel. The number funds from our database with holdings in Valeant Pharmaceuticals Intl Inc (NYSE:VRX) fell by 12 quarter-over-quarter to 71 at the end of March.

Follow Bausch Health Companies Inc. (NYSE:BHC)
Trade (NYSE:BHC) Now!

Kroger Co Rallies on Earnings

The Kroger Co (NYSE:KR) is one of the few stocks in the green today, having advanced by over 2%. The grocer reported earnings of $0.70 per share on revenue of $34.6 billion, beating earnings estimates by $0.01 per share, but missing revenue expectations by $280 million. Identical supermarket sales without fuel grew by 2.4% year-over-year and the company exceeded its goal of slightly expanding FIFO operating margin without fuel and Roundy’s on a rolling four-quarter basis. The number funds tracked by us with holdings in The Kroger Co (NYSE:KR) fell by nine quarter-over-quarter to 30 at the end of March.

Follow Kroger Co (NYSE:KR)
Trade (NYSE:KR) Now!

Disclosure: none

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.